Business ❯Financial Performance ❯Sales Growth

Quarterly Sales

Second Quarter 2024 $12.7 billion

AstraZeneca Reports Strong Q1 Growth Driven by Cancer Drug Sales

The pharmaceutical giant's earnings and revenue exceed expectations, bolstered by robust demand for oncology treatments.

AutoZone Reports Record Second-Quarter Earnings, Shares Hit All-Time High